MALT1
Basic information
Region (hg38): 18:58671465-58754477
Previous symbols: [ "MLT" ]
Links
Phenotypes
GenCC
Source:
- combined immunodeficiency due to MALT1 deficiency (Moderate), mode of inheritance: AR
- combined immunodeficiency due to MALT1 deficiency (Strong), mode of inheritance: AR
- combined immunodeficiency due to MALT1 deficiency (Supportive), mode of inheritance: AR
- combined immunodeficiency due to MALT1 deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Immunodeficiency 12 | AR | Allergy/Immunology/Infectious | Individuals have been described as suffering from primary immunodeficiency including infantile-onset recurrent bacterial and candidal infections, and awareness may allow prophylaxis and early and aggressive treatment of infections | Allergy/Immunology/Infectious | 23727036; 24332264 |
ClinVar
This is a list of variants' phenotypes submitted to
- Combined_immunodeficiency_due_to_MALT1_deficiency (396 variants)
- Inborn_genetic_diseases (56 variants)
- not_provided (33 variants)
- MALT1-related_disorder (9 variants)
- not_specified (2 variants)
- Severe_combined_immunodeficiency_disease (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MALT1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006785.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 109 | 112 | ||||
| missense | 173 | 183 | ||||
| nonsense | 6 | |||||
| start loss | 0 | |||||
| frameshift | 10 | 16 | ||||
| splice donor/acceptor (+/-2bp) | 5 | |||||
| Total | 15 | 11 | 177 | 115 | 4 |
Highest pathogenic variant AF is 0.000015162773
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MALT1 | protein_coding | protein_coding | ENST00000348428 | 17 | 78754 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.987 | 0.0135 | 125727 | 0 | 18 | 125745 | 0.0000716 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.84 | 229 | 386 | 0.593 | 0.0000185 | 5400 |
| Missense in Polyphen | 49 | 155.79 | 0.31453 | 2121 | ||
| Synonymous | 1.35 | 118 | 138 | 0.854 | 0.00000670 | 1549 |
| Loss of Function | 4.94 | 6 | 39.5 | 0.152 | 0.00000203 | 533 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000244 | 0.000243 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000991 | 0.0000967 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.0000329 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Enhances BCL10-induced activation of NF-kappa-B. Involved in nuclear export of BCL10. Binds to TRAF6, inducing TRAF6 oligomerization and activation of its ligase activity. Has ubiquitin ligase activity. MALT1-dependent BCL10 cleavage plays an important role in T-cell antigen receptor-induced integrin adhesion. Involved in the induction of T helper 17 cells (Th17) differentiation. Cleaves RC3H1 and ZC3H12A in response to T-cell receptor (TCR) stimulation which releases their cooperatively repressed targets to promote Th17 cell differentiation (By similarity). {ECO:0000250|UniProtKB:Q2TBA3, ECO:0000269|PubMed:11262391, ECO:0000269|PubMed:14695475, ECO:0000269|PubMed:18264101}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving MALT1 is recurrent in low-grade mucosa-associated lymphoid tissue (MALT lymphoma). Translocation t(11;18)(q21;q21) with BIRC2. This translocation is found in approximately 50% of cytogenetically abnormal low-grade MALT lymphoma. {ECO:0000269|PubMed:10339464, ECO:0000269|PubMed:10523859, ECO:0000269|PubMed:10702396, ECO:0000269|PubMed:11090634}.;
- Pathway
- T cell receptor signaling pathway - Homo sapiens (human);B cell receptor signaling pathway - Homo sapiens (human);C-type lectin receptor signaling pathway - Homo sapiens (human);Tuberculosis - Homo sapiens (human);NF-kappa B signaling pathway - Homo sapiens (human);B Cell Receptor Signaling Pathway;T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection;T-Cell antigen Receptor (TCR) Signaling Pathway;B cell receptor signaling;Downstream TCR signaling;TCR signaling;Activation of NF-kappaB in B cells;Signaling by the B Cell Receptor (BCR);CLEC7A/inflammasome pathway;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Fc epsilon receptor (FCERI) signaling;TCR;Innate Immune System;Immune System;Adaptive Immune System;Downstream signaling events of B Cell Receptor (BCR);BCR;BCR signaling pathway;FCERI mediated NF-kB activation;Canonical NF-kappaB pathway;TCR signaling in naïve CD8+ T cells;TCR signaling in naïve CD4+ T cells;CD4 T cell receptor signaling-NFkB cascade;CD4 T cell receptor signaling
(Consensus)
Recessive Scores
- pRec
- 0.166
Intolerance Scores
- loftool
- 0.492
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.77
Haploinsufficiency Scores
- pHI
- 0.142
- hipred
- Y
- hipred_score
- 0.853
- ghis
- 0.598
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.627
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Malt1
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- B-1 B cell differentiation;stimulatory C-type lectin receptor signaling pathway;positive regulation of T cell cytokine production;proteolysis;defense response;activation of NF-kappaB-inducing kinase activity;response to fungus;protein ubiquitination;positive regulation of protein ubiquitination;lipopolysaccharide-mediated signaling pathway;positive regulation of interleukin-2 production;Fc-epsilon receptor signaling pathway;T cell proliferation;B cell activation;regulation of apoptotic process;negative regulation of apoptotic process;positive regulation of I-kappaB kinase/NF-kappaB signaling;innate immune response;T cell receptor signaling pathway;regulation of T cell receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;nuclear export;protein complex oligomerization;positive regulation of T-helper 17 cell differentiation
- Cellular component
- fibrillar center;nucleus;nucleolus;cytoplasm;cytosol;CBM complex;protein-containing complex;perinuclear region of cytoplasm
- Molecular function
- protease binding;cysteine-type endopeptidase activity;ubiquitin-protein transferase activity;protein binding;peptidase activity;kinase activator activity;identical protein binding;protein self-association